The Lupus Clinical Investigators Network
(LuCIN)

Lupus Therapeutics created a novel network of leading academic institutions to help move clinical trials forward faster for sponsors and ensure patients enrolled in trials receive the best overall care and achieve the best outcomes.

The Lupus Clinical Investigators Network
(LuCIN)

Lupus Therapeutics created a novel network of leading academic institutions to help move clinical trials forward faster for sponsors and ensure patients enrolled in trials receive the best overall care and achieve the best outcomes.

Lupus Therapeutics created and oversees the Lupus Clinical Investigators Network (LuCIN), a North America-based lupus clinical trials network comprised of 57 of the most reputable academic research medical centers in the world. LuCIN leverages the expertise of more than 200 experienced clinician-scientists who are focused on lupus and more than 25,000 active lupus patients.

Supported by the Lupus Research Alliance and Lupus Therapeutics, LuCIN clinicians work collaboratively with our pharmaceutical company clients to identify potentially transformative treatments and conduct related clinical trials to evaluate the safety and effectiveness of new therapies for lupus. The investigators and other specialized personnel within LuCIN are experts at planning and conducting lupus clinical research on potential new ways to diagnose, monitor and treat lupus.

View investigator sites

Lupus Therapeutics created and oversees the Lupus Clinical Investigators Network (LuCIN), a North America-based lupus clinical trials network comprised of 57 of the most reputable academic research medical centers in the world. LuCIN leverages the expertise of more than 200 experienced clinician-scientists who are focused on lupus and more than 20,000 active lupus patients.

Supported by the Lupus Research Alliance and Lupus Therapeutics, LuCIN clinicians work collaboratively with our pharmaceutical company clients to identify potentially transformative treatments and conduct related clinical trials to evaluate the safety and effectiveness of new therapies for lupus. The investigators and other specialized personnel within LuCIN are experts at planning and conducting lupus clinical research on potential new ways to diagnose, monitor and treat lupus.

View investigator sites

The goals of LuCIN are to: 

Our value 

Combining LuCIN with Lupus Therapeutics’ full suite of resources and capabilities, including consultative and study start-up services, expedites and streamlines the research process resulting in earlier trial fielding, faster patient enrollment, and earlier trial completion.

While clinical research organizations (CROs) generally reach out to community-based hospitals for access to their patient populations, Lupus Therapeutics developed this novel network of leading academic institutions because lupus patients enrolled in studies at academic centers typically receive better overall care and achieve better patient compliance. Lupus-focused academic centers contacted by CROs frequently refer them to Lupus Therapeutics because of our established contracts and ecosystem of relationships.